Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(33%)
Results Posted
100%(4 trials)

Phase Distribution

Ph phase_2
1
17%
Ph phase_4
4
67%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(4)

Detailed Status

Completed4
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 44 (66.7%)

Trials by Status

recruiting233%
completed467%

Recent Activity

2 active trials
Showing 5 of 6
recruitingphase_4

Vaccine Responses in Patients With B Cell Malignancies

NCT05170399
recruitingphase_4

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

NCT04101838
completedphase_1

First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults

NCT04896086
completedphase_4

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

NCT03722589
completedphase_2

Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine

NCT04025580
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05170399Phase 4

Vaccine Responses in Patients With B Cell Malignancies

Recruiting
NCT04101838Phase 4

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

Recruiting
NCT04896086Phase 1

First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults

Completed
NCT03722589Phase 4

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Completed
NCT04025580Phase 2

Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine

Completed
NCT03068949Phase 4

Comparison of Three Licensed Influenza Vaccines

Completed

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6